Pharma & Healthcare
Antiretroviral Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 554048
- Pages: 101
- Figures: 206
- Views: 1
The global market for Antiretroviral Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antiretroviral Therapy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antiretroviral Therapy by region & country, by Type, and by Application.
The Antiretroviral Therapy market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiretroviral Therapy.
Market Segmentation
By Company
Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Segment by Type:
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antiretroviral Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antiretroviral Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antiretroviral Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antiretroviral Therapy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antiretroviral Therapy by region & country, by Type, and by Application.
The Antiretroviral Therapy market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiretroviral Therapy.
Market Segmentation
By Company
Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Segment by Type:
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antiretroviral Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antiretroviral Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antiretroviral Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Antiretroviral Therapy Product Introduction
1.2 Global Antiretroviral Therapy Market Size Forecast
1.2.1 Global Antiretroviral Therapy Sales Value (2019-2030)
1.2.2 Global Antiretroviral Therapy Sales Volume (2019-2030)
1.2.3 Global Antiretroviral Therapy Sales Price (2019-2030)
1.3 Antiretroviral Therapy Market Trends & Drivers
1.3.1 Antiretroviral Therapy Industry Trends
1.3.2 Antiretroviral Therapy Market Drivers & Opportunity
1.3.3 Antiretroviral Therapy Market Challenges
1.3.4 Antiretroviral Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antiretroviral Therapy Players Revenue Ranking (2023)
2.2 Global Antiretroviral Therapy Revenue by Company (2019-2024)
2.3 Global Antiretroviral Therapy Players Sales Volume Ranking (2023)
2.4 Global Antiretroviral Therapy Sales Volume by Company Players (2019-2024)
2.5 Global Antiretroviral Therapy Average Price by Company (2019-2024)
2.6 Key Manufacturers Antiretroviral Therapy Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antiretroviral Therapy Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antiretroviral Therapy
2.9 Antiretroviral Therapy Market Competitive Analysis
2.9.1 Antiretroviral Therapy Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antiretroviral Therapy Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NNRTIs
3.1.2 NRTI
3.1.3 Multiclass Combination Products
3.1.4 Integrase Inhibitors
3.2 Global Antiretroviral Therapy Sales Value by Type
3.2.1 Global Antiretroviral Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antiretroviral Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Antiretroviral Therapy Sales Value, by Type (%) (2019-2030)
3.3 Global Antiretroviral Therapy Sales Volume by Type
3.3.1 Global Antiretroviral Therapy Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antiretroviral Therapy Sales Volume, by Type (2019-2030)
3.3.3 Global Antiretroviral Therapy Sales Volume, by Type (%) (2019-2030)
3.4 Global Antiretroviral Therapy Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Antiretroviral Therapy Sales Value by Application
4.2.1 Global Antiretroviral Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antiretroviral Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Antiretroviral Therapy Sales Value, by Application (%) (2019-2030)
4.3 Global Antiretroviral Therapy Sales Volume by Application
4.3.1 Global Antiretroviral Therapy Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antiretroviral Therapy Sales Volume, by Application (2019-2030)
4.3.3 Global Antiretroviral Therapy Sales Volume, by Application (%) (2019-2030)
4.4 Global Antiretroviral Therapy Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antiretroviral Therapy Sales Value by Region
5.1.1 Global Antiretroviral Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antiretroviral Therapy Sales Value by Region (2019-2024)
5.1.3 Global Antiretroviral Therapy Sales Value by Region (2025-2030)
5.1.4 Global Antiretroviral Therapy Sales Value by Region (%), (2019-2030)
5.2 Global Antiretroviral Therapy Sales Volume by Region
5.2.1 Global Antiretroviral Therapy Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antiretroviral Therapy Sales Volume by Region (2019-2024)
5.2.3 Global Antiretroviral Therapy Sales Volume by Region (2025-2030)
5.2.4 Global Antiretroviral Therapy Sales Volume by Region (%), (2019-2030)
5.3 Global Antiretroviral Therapy Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antiretroviral Therapy Sales Value, 2019-2030
5.4.2 North America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antiretroviral Therapy Sales Value, 2019-2030
5.5.2 Europe Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antiretroviral Therapy Sales Value, 2019-2030
5.6.2 Asia Pacific Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antiretroviral Therapy Sales Value, 2019-2030
5.7.2 South America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antiretroviral Therapy Sales Value, 2019-2030
5.8.2 Middle East & Africa Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antiretroviral Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antiretroviral Therapy Sales Value
6.2.1 Key Countries/Regions Antiretroviral Therapy Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antiretroviral Therapy Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antiretroviral Therapy Sales Value, 2019-2030
6.3.2 United States Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antiretroviral Therapy Sales Value, 2019-2030
6.4.2 Europe Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antiretroviral Therapy Sales Value, 2019-2030
6.5.2 China Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antiretroviral Therapy Sales Value, 2019-2030
6.6.2 Japan Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antiretroviral Therapy Sales Value, 2019-2030
6.7.2 South Korea Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antiretroviral Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antiretroviral Therapy Sales Value, 2019-2030
6.9.2 India Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gilead
7.1.1 Gilead Company Information
7.1.2 Gilead Introduction and Business Overview
7.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gilead Antiretroviral Therapy Product Offerings
7.1.5 Gilead Recent Development
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Information
7.2.2 F. Hoffmann-La Roche Introduction and Business Overview
7.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Offerings
7.2.5 F. Hoffmann-La Roche Recent Development
7.3 ViiV Healthcare
7.3.1 ViiV Healthcare Company Information
7.3.2 ViiV Healthcare Introduction and Business Overview
7.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.3.4 ViiV Healthcare Antiretroviral Therapy Product Offerings
7.3.5 ViiV Healthcare Recent Development
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Information
7.4.2 Boehringer Ingelheim Introduction and Business Overview
7.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Offerings
7.4.5 Boehringer Ingelheim Recent Development
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Information
7.5.2 Janssen Pharmaceuticals Introduction and Business Overview
7.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Offerings
7.5.5 Janssen Pharmaceuticals Recent Development
7.6 Mylan
7.6.1 Mylan Company Information
7.6.2 Mylan Introduction and Business Overview
7.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mylan Antiretroviral Therapy Product Offerings
7.6.5 Mylan Recent Development
7.7 Abbvie
7.7.1 Abbvie Company Information
7.7.2 Abbvie Introduction and Business Overview
7.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Abbvie Antiretroviral Therapy Product Offerings
7.7.5 Abbvie Recent Development
7.8 Bionor Pharma
7.8.1 Bionor Pharma Company Information
7.8.2 Bionor Pharma Introduction and Business Overview
7.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bionor Pharma Antiretroviral Therapy Product Offerings
7.8.5 Bionor Pharma Recent Development
7.9 Vertex Pharmaceuticals
7.9.1 Vertex Pharmaceuticals Company Information
7.9.2 Vertex Pharmaceuticals Introduction and Business Overview
7.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Offerings
7.9.5 Vertex Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Antiretroviral Therapy Industrial Chain
8.2 Antiretroviral Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antiretroviral Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Antiretroviral Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Antiretroviral Therapy Product Introduction
1.2 Global Antiretroviral Therapy Market Size Forecast
1.2.1 Global Antiretroviral Therapy Sales Value (2019-2030)
1.2.2 Global Antiretroviral Therapy Sales Volume (2019-2030)
1.2.3 Global Antiretroviral Therapy Sales Price (2019-2030)
1.3 Antiretroviral Therapy Market Trends & Drivers
1.3.1 Antiretroviral Therapy Industry Trends
1.3.2 Antiretroviral Therapy Market Drivers & Opportunity
1.3.3 Antiretroviral Therapy Market Challenges
1.3.4 Antiretroviral Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antiretroviral Therapy Players Revenue Ranking (2023)
2.2 Global Antiretroviral Therapy Revenue by Company (2019-2024)
2.3 Global Antiretroviral Therapy Players Sales Volume Ranking (2023)
2.4 Global Antiretroviral Therapy Sales Volume by Company Players (2019-2024)
2.5 Global Antiretroviral Therapy Average Price by Company (2019-2024)
2.6 Key Manufacturers Antiretroviral Therapy Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antiretroviral Therapy Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antiretroviral Therapy
2.9 Antiretroviral Therapy Market Competitive Analysis
2.9.1 Antiretroviral Therapy Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antiretroviral Therapy Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NNRTIs
3.1.2 NRTI
3.1.3 Multiclass Combination Products
3.1.4 Integrase Inhibitors
3.2 Global Antiretroviral Therapy Sales Value by Type
3.2.1 Global Antiretroviral Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antiretroviral Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Antiretroviral Therapy Sales Value, by Type (%) (2019-2030)
3.3 Global Antiretroviral Therapy Sales Volume by Type
3.3.1 Global Antiretroviral Therapy Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antiretroviral Therapy Sales Volume, by Type (2019-2030)
3.3.3 Global Antiretroviral Therapy Sales Volume, by Type (%) (2019-2030)
3.4 Global Antiretroviral Therapy Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Antiretroviral Therapy Sales Value by Application
4.2.1 Global Antiretroviral Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antiretroviral Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Antiretroviral Therapy Sales Value, by Application (%) (2019-2030)
4.3 Global Antiretroviral Therapy Sales Volume by Application
4.3.1 Global Antiretroviral Therapy Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antiretroviral Therapy Sales Volume, by Application (2019-2030)
4.3.3 Global Antiretroviral Therapy Sales Volume, by Application (%) (2019-2030)
4.4 Global Antiretroviral Therapy Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antiretroviral Therapy Sales Value by Region
5.1.1 Global Antiretroviral Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antiretroviral Therapy Sales Value by Region (2019-2024)
5.1.3 Global Antiretroviral Therapy Sales Value by Region (2025-2030)
5.1.4 Global Antiretroviral Therapy Sales Value by Region (%), (2019-2030)
5.2 Global Antiretroviral Therapy Sales Volume by Region
5.2.1 Global Antiretroviral Therapy Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antiretroviral Therapy Sales Volume by Region (2019-2024)
5.2.3 Global Antiretroviral Therapy Sales Volume by Region (2025-2030)
5.2.4 Global Antiretroviral Therapy Sales Volume by Region (%), (2019-2030)
5.3 Global Antiretroviral Therapy Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antiretroviral Therapy Sales Value, 2019-2030
5.4.2 North America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antiretroviral Therapy Sales Value, 2019-2030
5.5.2 Europe Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antiretroviral Therapy Sales Value, 2019-2030
5.6.2 Asia Pacific Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antiretroviral Therapy Sales Value, 2019-2030
5.7.2 South America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antiretroviral Therapy Sales Value, 2019-2030
5.8.2 Middle East & Africa Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antiretroviral Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antiretroviral Therapy Sales Value
6.2.1 Key Countries/Regions Antiretroviral Therapy Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antiretroviral Therapy Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antiretroviral Therapy Sales Value, 2019-2030
6.3.2 United States Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antiretroviral Therapy Sales Value, 2019-2030
6.4.2 Europe Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antiretroviral Therapy Sales Value, 2019-2030
6.5.2 China Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antiretroviral Therapy Sales Value, 2019-2030
6.6.2 Japan Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antiretroviral Therapy Sales Value, 2019-2030
6.7.2 South Korea Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antiretroviral Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antiretroviral Therapy Sales Value, 2019-2030
6.9.2 India Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antiretroviral Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gilead
7.1.1 Gilead Company Information
7.1.2 Gilead Introduction and Business Overview
7.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gilead Antiretroviral Therapy Product Offerings
7.1.5 Gilead Recent Development
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Information
7.2.2 F. Hoffmann-La Roche Introduction and Business Overview
7.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Offerings
7.2.5 F. Hoffmann-La Roche Recent Development
7.3 ViiV Healthcare
7.3.1 ViiV Healthcare Company Information
7.3.2 ViiV Healthcare Introduction and Business Overview
7.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.3.4 ViiV Healthcare Antiretroviral Therapy Product Offerings
7.3.5 ViiV Healthcare Recent Development
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Information
7.4.2 Boehringer Ingelheim Introduction and Business Overview
7.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Offerings
7.4.5 Boehringer Ingelheim Recent Development
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Information
7.5.2 Janssen Pharmaceuticals Introduction and Business Overview
7.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Offerings
7.5.5 Janssen Pharmaceuticals Recent Development
7.6 Mylan
7.6.1 Mylan Company Information
7.6.2 Mylan Introduction and Business Overview
7.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mylan Antiretroviral Therapy Product Offerings
7.6.5 Mylan Recent Development
7.7 Abbvie
7.7.1 Abbvie Company Information
7.7.2 Abbvie Introduction and Business Overview
7.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Abbvie Antiretroviral Therapy Product Offerings
7.7.5 Abbvie Recent Development
7.8 Bionor Pharma
7.8.1 Bionor Pharma Company Information
7.8.2 Bionor Pharma Introduction and Business Overview
7.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bionor Pharma Antiretroviral Therapy Product Offerings
7.8.5 Bionor Pharma Recent Development
7.9 Vertex Pharmaceuticals
7.9.1 Vertex Pharmaceuticals Company Information
7.9.2 Vertex Pharmaceuticals Introduction and Business Overview
7.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Offerings
7.9.5 Vertex Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Antiretroviral Therapy Industrial Chain
8.2 Antiretroviral Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antiretroviral Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Antiretroviral Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Antiretroviral Therapy Market Trends
Table 2. Antiretroviral Therapy Market Drivers & Opportunity
Table 3. Antiretroviral Therapy Market Challenges
Table 4. Antiretroviral Therapy Market Restraints
Table 5. Global Antiretroviral Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antiretroviral Therapy Revenue Market Share by Company (2019-2024)
Table 7. Global Antiretroviral Therapy Sales Volume by Company (2019-2024) & (KG)
Table 8. Global Antiretroviral Therapy Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Antiretroviral Therapy Price by Company (2019-2024) & (US$/KG)
Table 10. Key Manufacturers Antiretroviral Therapy Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Antiretroviral Therapy Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Antiretroviral Therapy
Table 13. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiretroviral Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Antiretroviral Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Antiretroviral Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Antiretroviral Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Antiretroviral Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Antiretroviral Therapy Sales Volume by Type: 2019 VS 2023 VS 2030 (KG)
Table 22. Global Antiretroviral Therapy Sales Volume by Type (2019-2024) & (KG)
Table 23. Global Antiretroviral Therapy Sales Volume by Type (2025-2030) & (KG)
Table 24. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Antiretroviral Therapy Price by Type (2019-2024) & (US$/KG)
Table 27. Global Antiretroviral Therapy Price by Type (2025-2030) & (US$/KG)
Table 28. Global Antiretroviral Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Antiretroviral Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Antiretroviral Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Antiretroviral Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Antiretroviral Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Antiretroviral Therapy Sales Volume by Application: 2019 VS 2023 VS 2030 (KG)
Table 34. Global Antiretroviral Therapy Sales Volume by Application (2019-2024) & (KG)
Table 35. Global Antiretroviral Therapy Sales Volume by Application (2025-2030) & (KG)
Table 36. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Antiretroviral Therapy Price by Application (2019-2024) & (US$/KG)
Table 39. Global Antiretroviral Therapy Price by Application (2025-2030) & (US$/KG)
Table 40. Global Antiretroviral Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Antiretroviral Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Antiretroviral Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Antiretroviral Therapy Sales Value by Region (2019-2024) & (%)
Table 44. Global Antiretroviral Therapy Sales Value by Region (2025-2030) & (%)
Table 45. Global Antiretroviral Therapy Sales Volume by Region (KG): 2019 VS 2023 VS 2030
Table 46. Global Antiretroviral Therapy Sales Volume by Region (2019-2024) & (KG)
Table 47. Global Antiretroviral Therapy Sales Volume by Region (2025-2030) & (KG)
Table 48. Global Antiretroviral Therapy Sales Volume by Region (2019-2024) & (%)
Table 49. Global Antiretroviral Therapy Sales Volume by Region (2025-2030) & (%)
Table 50. Global Antiretroviral Therapy Average Price by Region (2019-2024) & (US$/KG)
Table 51. Global Antiretroviral Therapy Average Price by Region (2025-2030) & (US$/KG)
Table 52. Key Countries/Regions Antiretroviral Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Antiretroviral Therapy Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Antiretroviral Therapy Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Antiretroviral Therapy Sales Volume, (2019-2024) & (KG)
Table 56. Key Countries/Regions Antiretroviral Therapy Sales Volume, (2025-2030) & (KG)
Table 57. Gilead Company Information
Table 58. Gilead Introduction and Business Overview
Table 59. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 60. Gilead Antiretroviral Therapy Product Offerings
Table 61. Gilead Recent Development
Table 62. F. Hoffmann-La Roche Company Information
Table 63. F. Hoffmann-La Roche Introduction and Business Overview
Table 64. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 65. F. Hoffmann-La Roche Antiretroviral Therapy Product Offerings
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. ViiV Healthcare Company Information
Table 68. ViiV Healthcare Introduction and Business Overview
Table 69. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 70. ViiV Healthcare Antiretroviral Therapy Product Offerings
Table 71. ViiV Healthcare Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Introduction and Business Overview
Table 74. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Antiretroviral Therapy Product Offerings
Table 76. Boehringer Ingelheim Recent Development
Table 77. Janssen Pharmaceuticals Company Information
Table 78. Janssen Pharmaceuticals Introduction and Business Overview
Table 79. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 80. Janssen Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 81. Janssen Pharmaceuticals Recent Development
Table 82. Mylan Company Information
Table 83. Mylan Introduction and Business Overview
Table 84. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 85. Mylan Antiretroviral Therapy Product Offerings
Table 86. Mylan Recent Development
Table 87. Abbvie Company Information
Table 88. Abbvie Introduction and Business Overview
Table 89. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 90. Abbvie Antiretroviral Therapy Product Offerings
Table 91. Abbvie Recent Development
Table 92. Bionor Pharma Company Information
Table 93. Bionor Pharma Introduction and Business Overview
Table 94. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 95. Bionor Pharma Antiretroviral Therapy Product Offerings
Table 96. Bionor Pharma Recent Development
Table 97. Vertex Pharmaceuticals Company Information
Table 98. Vertex Pharmaceuticals Introduction and Business Overview
Table 99. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 100. Vertex Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 101. Vertex Pharmaceuticals Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Antiretroviral Therapy Downstream Customers
Table 105. Antiretroviral Therapy Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Antiretroviral Therapy Sales Volume (2019-2030) & (KG)
Figure 5. Global Antiretroviral Therapy Sales Price (2019-2030) & (US$/KG)
Figure 6. Antiretroviral Therapy Report Years Considered
Figure 7. Global Antiretroviral Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Antiretroviral Therapy Players Sales Volume Ranking (2023) & (KG)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiretroviral Therapy Revenue in 2023
Figure 10. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. NNRTIs Picture
Figure 12. NRTI Picture
Figure 13. Multiclass Combination Products Picture
Figure 14. Integrase Inhibitors Picture
Figure 15. Global Antiretroviral Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Antiretroviral Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Antiretroviral Therapy Sales Volume by Type (2019 VS 2023 VS 2030) & (KG)
Figure 18. Global Antiretroviral Therapy Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Antiretroviral Therapy Price by Type (2019-2030) & (US$/KG)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Clinic
Figure 22. Product Picture of Other
Figure 23. Global Antiretroviral Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Antiretroviral Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Antiretroviral Therapy Sales Volume by Application (2019 VS 2023 VS 2030) & (KG)
Figure 26. Global Antiretroviral Therapy Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Antiretroviral Therapy Price by Application (2019-2030) & (US$/KG)
Figure 28. North America Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Antiretroviral Therapy Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Antiretroviral Therapy Sales Volume (%), (2019-2030)
Figure 40. United States Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. China Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. China Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 58. India Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 60. India Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 61. Antiretroviral Therapy Industrial Chain
Figure 62. Antiretroviral Therapy Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Antiretroviral Therapy Market Trends
Table 2. Antiretroviral Therapy Market Drivers & Opportunity
Table 3. Antiretroviral Therapy Market Challenges
Table 4. Antiretroviral Therapy Market Restraints
Table 5. Global Antiretroviral Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antiretroviral Therapy Revenue Market Share by Company (2019-2024)
Table 7. Global Antiretroviral Therapy Sales Volume by Company (2019-2024) & (KG)
Table 8. Global Antiretroviral Therapy Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Antiretroviral Therapy Price by Company (2019-2024) & (US$/KG)
Table 10. Key Manufacturers Antiretroviral Therapy Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Antiretroviral Therapy Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Antiretroviral Therapy
Table 13. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiretroviral Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Antiretroviral Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Antiretroviral Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Antiretroviral Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Antiretroviral Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Antiretroviral Therapy Sales Volume by Type: 2019 VS 2023 VS 2030 (KG)
Table 22. Global Antiretroviral Therapy Sales Volume by Type (2019-2024) & (KG)
Table 23. Global Antiretroviral Therapy Sales Volume by Type (2025-2030) & (KG)
Table 24. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Antiretroviral Therapy Price by Type (2019-2024) & (US$/KG)
Table 27. Global Antiretroviral Therapy Price by Type (2025-2030) & (US$/KG)
Table 28. Global Antiretroviral Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Antiretroviral Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Antiretroviral Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Antiretroviral Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Antiretroviral Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Antiretroviral Therapy Sales Volume by Application: 2019 VS 2023 VS 2030 (KG)
Table 34. Global Antiretroviral Therapy Sales Volume by Application (2019-2024) & (KG)
Table 35. Global Antiretroviral Therapy Sales Volume by Application (2025-2030) & (KG)
Table 36. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Antiretroviral Therapy Price by Application (2019-2024) & (US$/KG)
Table 39. Global Antiretroviral Therapy Price by Application (2025-2030) & (US$/KG)
Table 40. Global Antiretroviral Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Antiretroviral Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Antiretroviral Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Antiretroviral Therapy Sales Value by Region (2019-2024) & (%)
Table 44. Global Antiretroviral Therapy Sales Value by Region (2025-2030) & (%)
Table 45. Global Antiretroviral Therapy Sales Volume by Region (KG): 2019 VS 2023 VS 2030
Table 46. Global Antiretroviral Therapy Sales Volume by Region (2019-2024) & (KG)
Table 47. Global Antiretroviral Therapy Sales Volume by Region (2025-2030) & (KG)
Table 48. Global Antiretroviral Therapy Sales Volume by Region (2019-2024) & (%)
Table 49. Global Antiretroviral Therapy Sales Volume by Region (2025-2030) & (%)
Table 50. Global Antiretroviral Therapy Average Price by Region (2019-2024) & (US$/KG)
Table 51. Global Antiretroviral Therapy Average Price by Region (2025-2030) & (US$/KG)
Table 52. Key Countries/Regions Antiretroviral Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Antiretroviral Therapy Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Antiretroviral Therapy Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Antiretroviral Therapy Sales Volume, (2019-2024) & (KG)
Table 56. Key Countries/Regions Antiretroviral Therapy Sales Volume, (2025-2030) & (KG)
Table 57. Gilead Company Information
Table 58. Gilead Introduction and Business Overview
Table 59. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 60. Gilead Antiretroviral Therapy Product Offerings
Table 61. Gilead Recent Development
Table 62. F. Hoffmann-La Roche Company Information
Table 63. F. Hoffmann-La Roche Introduction and Business Overview
Table 64. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 65. F. Hoffmann-La Roche Antiretroviral Therapy Product Offerings
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. ViiV Healthcare Company Information
Table 68. ViiV Healthcare Introduction and Business Overview
Table 69. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 70. ViiV Healthcare Antiretroviral Therapy Product Offerings
Table 71. ViiV Healthcare Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Introduction and Business Overview
Table 74. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Antiretroviral Therapy Product Offerings
Table 76. Boehringer Ingelheim Recent Development
Table 77. Janssen Pharmaceuticals Company Information
Table 78. Janssen Pharmaceuticals Introduction and Business Overview
Table 79. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 80. Janssen Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 81. Janssen Pharmaceuticals Recent Development
Table 82. Mylan Company Information
Table 83. Mylan Introduction and Business Overview
Table 84. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 85. Mylan Antiretroviral Therapy Product Offerings
Table 86. Mylan Recent Development
Table 87. Abbvie Company Information
Table 88. Abbvie Introduction and Business Overview
Table 89. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 90. Abbvie Antiretroviral Therapy Product Offerings
Table 91. Abbvie Recent Development
Table 92. Bionor Pharma Company Information
Table 93. Bionor Pharma Introduction and Business Overview
Table 94. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 95. Bionor Pharma Antiretroviral Therapy Product Offerings
Table 96. Bionor Pharma Recent Development
Table 97. Vertex Pharmaceuticals Company Information
Table 98. Vertex Pharmaceuticals Introduction and Business Overview
Table 99. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 100. Vertex Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 101. Vertex Pharmaceuticals Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Antiretroviral Therapy Downstream Customers
Table 105. Antiretroviral Therapy Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Antiretroviral Therapy Sales Volume (2019-2030) & (KG)
Figure 5. Global Antiretroviral Therapy Sales Price (2019-2030) & (US$/KG)
Figure 6. Antiretroviral Therapy Report Years Considered
Figure 7. Global Antiretroviral Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Antiretroviral Therapy Players Sales Volume Ranking (2023) & (KG)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiretroviral Therapy Revenue in 2023
Figure 10. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. NNRTIs Picture
Figure 12. NRTI Picture
Figure 13. Multiclass Combination Products Picture
Figure 14. Integrase Inhibitors Picture
Figure 15. Global Antiretroviral Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Antiretroviral Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Antiretroviral Therapy Sales Volume by Type (2019 VS 2023 VS 2030) & (KG)
Figure 18. Global Antiretroviral Therapy Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Antiretroviral Therapy Price by Type (2019-2030) & (US$/KG)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Clinic
Figure 22. Product Picture of Other
Figure 23. Global Antiretroviral Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Antiretroviral Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Antiretroviral Therapy Sales Volume by Application (2019 VS 2023 VS 2030) & (KG)
Figure 26. Global Antiretroviral Therapy Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Antiretroviral Therapy Price by Application (2019-2030) & (US$/KG)
Figure 28. North America Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Antiretroviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Antiretroviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Antiretroviral Therapy Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Antiretroviral Therapy Sales Volume (%), (2019-2030)
Figure 40. United States Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. China Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. China Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 58. India Antiretroviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Antiretroviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 60. India Antiretroviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 61. Antiretroviral Therapy Industrial Chain
Figure 62. Antiretroviral Therapy Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232